8/13/2019 Bipasha Fin. Acc. Assignment

1/16

Analysis & InterpretationAnalysis & Interpretation

Of Financial Statement OfOf Financial Statement Of

Beximco Pharmaceutical LimitedBeximco Pharmaceutical Limited

Submitted ToSubmitted To

Prof. r. !asnan AhmedProf. r. !asnan AhmedProf

Professor Of Accounting& Director, BBA Program

School of Business & "conomics

Financial Accountin#$A%% '()

Submitted BySubmitted By

Bipasha asI* ++(++,'-+

Section* BSemester* Sprin# ('+(

/BA Pro#ram/BA Pro#ram

Submission ateSubmission ate

28th April, 2012

(School of Business)

0nited International 0ni1ersity

1

8/13/2019 Bipasha Fin. Acc. Assignment

2/16

Introduction

B"2I/%O P!A3/A%"0TI%ALS LT elongs to Be!imco group, the largest pri"ate

sector in#ustrial corporation in Bangla#esh$ Be!imco Pharma is one of the lea#ing

Pharmaceuticals %ompan in Bangla#esh$ 'he compan is pro#ucing orl# class of e#icine,

folloing the re*uirement of the +orl# ealth Organi-ation (+O) in or#er to impro"e the

health happiness an# the $*uantit of life$ +e place# greatest emphasis on maintaining the

highest stan#ar# of the %orporate .o"ernance$ On the asis of /inancial Statement e can

#escries ho the principles of the goo# .o"ernance is applie# in Be!imco Pharmaceuticals t#$

'he Be!imco Pharmaceuticals t#$committe# to efforts our health care nee#s of the countr,

aout (4ne pro#ucts ha"e een a##e# to the e!isting pro#ucts #uring this ear$ As a result

'riocim, Prosan, eco!, Ato"a, an# lot of me#icine are alrea# achie"ing themsel"es in a goo#

position in the orl# aret ithin a short perio# of time$ But Be!imco Pharmaceuticals t#$

%ompan3s superstar pro#uct 45APA6 continue# to retain the numer of one position since

17703s$

Be!imco Pharma pro#uces pharmaceutical formulations an# acti"e pharmaceutical ingre#ients,

ha"ing a current portfolio of more than 00 pro#ucts an# a #e#icate# team of more than 2,900

emploees$ :n its long ;ourne o"er three #eca#es, the simple principle on hich it as foun#e#

remains the same< pro#ucing high=*ualit generics an# pro"i#ing etter access to me#icines at a

much affor#ale cost$

'he compan continues to a#here to the gloal stan#ar#s an# taes initiati"es to remain more

competiti"e in or#er to maintain its strong trac recor#$

/ission*>ach of our acti"ities must enefit an# a## "alue to the common ealth of our

societ$ +e confi#entl elie"e that, in the final analsis e are accountale to each of the

constituents ith hom e interact, namel< our emploees, our customers, our usiness

associates, our fello citi-ens an# sharehol#ers